REQUEST A DEMO
Total
USD $0.00
Search more companies

Level Biotechnology Inc. (进阶生物科技股份有限公司) (Taiwan, China)

Main Activities: Machinery, Equipment, and Supplies Merchant Wholesalers | Drugs and Druggists' Sundries Merchant Wholesalers | Research and Development in the Physical, Engineering, and Life Sciences
Full name: Level Biotechnology Inc. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Level Biotechnology is a biotech company in Taiwan. The company offers preclinical testing services, including mammalian toxicology, genetic toxicology, and pharmacology. Additionally, Level Biotechnology provides a range of consumable and reagents, as well as chemical synthesis and immune & molecular cell biology instruments.

Headquarters
No.80,Lane 169, Kang Ning St., Hsi-Chih
New Taipei City; New Taipei City;

Contact Details: Purchase the Level Biotechnology Inc. (进阶生物科技股份有限公司) report to view the information.

Website: http://www.level.com.tw

Basic Information
Total Employees:
Purchase the Level Biotechnology Inc. (进阶生物科技股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Level Biotechnology Inc. (进阶生物科技股份有限公司) report to view the information.
Financial Auditors:
Purchase the Level Biotechnology Inc. (进阶生物科技股份有限公司) report to view the information.
Incorporation Date:
December 07, 1989
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
8.65%
Purchase this report to view the information.
4%
Purchase this report to view the information.
2.48%
Purchase this report to view the information.
2.48%
Purchase this report to view the information.
2.4%
Subsidiaries
Horien Biochemical Technology Co., Ltd.
0.82%
Hwa Hsying Biotechnology Co., Ltd.
0.01%
Company Performance
Financial values in the chart are available after Level Biotechnology Inc. (进阶生物科技股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
4.17%
Total operating revenue
4.2%
Operating Profit/Loss (EBIT)
34.33%
EBITDA
15.76%
Net Profit/Loss for the Period
35.2%
Total Assets
0.27%
Total Equity
4.29%
Operating Profit Margin (ROS)
2.91%
Net Profit Margin
2.57%
Return on Equity (ROE)
2.5%
Debt/Equity
-0.93%
Quick Ratio
-0.7%
Cash Ratio
-0.79%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?